المؤلفون: Puig, Noemi, Hernández, Miguel T, Rosiñol, Laura, González, Esther, de Arriba, Felipe, Oriol, Albert, González-Calle, Verónica, Escalante, Fernando, de la Rubia, Javier, Gironella, Mercedes, Ríos, Rafael, García-Sánchez, Ricarda, Arguiñano, José M, Alegre, Adrián, Martín, Jesús, Gutiérrez, Norma C, Calasanz, María J, Martín, María L, Couto, María Del Carmen, Casanova, María, Arnao, Mario, Pérez-Persona, Ernesto, Garzón, Sebastián, González, Marta S, Martín-Sánchez, Guillermo, Ocio, Enrique M, Coleman, Morton, Encinas, Cristina, Vale, Ana M, Teruel, Ana I, Cortés-Rodríguez, María, Paiva, Bruno, Cedena, M Teresa, San-Miguel, Jesús F, Lahuerta, Juan J, Bladé, Joan, Niesvizky, Ruben, Mateos, María-Victoria

مصطلحات موضوعية: Aged, 80 and over, Antineoplastic Combined Chemotherapy Protocols, Clarithromycin, Dexamethasone, Female, Hematopoietic Stem Cell Transplantation, Humans, Lenalidomide, Male, Multiple Myeloma, Transplantation, Autologous, Treatment Outcome

وصف الملف: application/pdf

العلاقة: http://hdl.handle.net/10668/17818Test; PMC8139975; https://www.nature.com/articles/s41408-021-00490-8.pdfTest; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139975/pdfTest

الإتاحة: https://doi.org/10.1038/s41408-021-00490-8Test
http://hdl.handle.net/10668/17818Test
https://www.nature.com/articles/s41408-021-00490-8.pdfTest
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8139975/pdfTest

المؤلفون: Mateos, María-Victoria, Martínez-López, Joaquín, Hernández, Miguel-Teodoro, Ocio, Enrique-M, Rosiñol, Laura, Martínez, Rafael, Teruel, Ana-Isabel, Gutiérrez, Norma C, Martín Ramos, María-Luisa, Oriol, Albert, Bargay, Joan, Bengoechea, Enrique, González, Yolanda, Pérez de Oteyza, Jaime, Gironella, Mercedes, Encinas, Cristina, Martín, Jesús, Cabrera, Carmen, Paiva, Bruno, Cedena, María-Teresa, Puig, Noemí, Bladé, Joan, Lahuerta, Juan-José, San-Miguel, Jesús

مصطلحات موضوعية: Aged, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Bortezomib, Dexamethasone, Female, Humans, Lenalidomide, Male, Melphalan, Multiple Myeloma, Prednisone, Thalidomide, Treatment Outcome

العلاقة: http://hdl.handle.net/10668/10516Test; https://ashpublications.org/blood/article-pdf/127/4/420/1394800/420.pdfTest

الإتاحة: https://doi.org/10.1182/blood-2015-08-666537Test
http://hdl.handle.net/10668/10516Test
https://ashpublications.org/blood/article-pdf/127/4/420/1394800/420.pdfTest

المؤلفون: Paiva, Bruno, Cedena, Maria-Teresa, Puig, Noemi, Arana, Paula, Vidriales, Maria-Belen, Cordon, Lourdes, Flores-Montero, Juan, Gutierrez, Norma C, Martín-Ramos, María-Luisa, Martinez-Lopez, Joaquin, Ocio, Enrique M, Hernandez, Miguel T, Teruel, Ana-Isabel, Rosiñol, Laura, Echeveste, María-Asunción, Martinez, Rafael, Gironella, Mercedes, Oriol, Albert, Cabrera, Carmen, Martin, Jesus, Bargay, Joan, Encinas, Cristina, Gonzalez, Yolanda, Van Dongen, Jacques J M, Orfao, Alberto, Bladé, Joan, Mateos, Maria-Victoria, Lahuerta, Juan José, San Miguel, Jesús F, Grupo Español de Mieloma/Programa para el Estudio de la Terapéutica en Hemopatías Malignas (GEM/PETHEMA) Cooperative Study Groups

المساهمون: Instituto de Salud Carlos III, Red Temática de Investigación Cooperativa en Cáncer (España), Asociación Española Contra el Cáncer, International Myeloma Foundation, European Research Council, Immunology

المصدر: BLOOD
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Blood
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Digital.CSIC. Repositorio Institucional del CSIC
Blood, 127(25), 3165-3174. American Society of Hematology

مصطلحات موضوعية: Male, Oncology, Pediatrics, Neoplasm, Residual, Biochemistry, Biomarkers, Pharmacological, Dexamethasone, law.invention, 0302 clinical medicine, Randomized controlled trial, law, hemic and lymphatic diseases, Antineoplastic Combined Chemotherapy Protocols, Medicine, Lenalidomide, Melphalan, Multiple myeloma, Aged, 80 and over, Hematology, Prognosis, Thalidomide, 3. Good health, Vincristine, 030220 oncology & carcinogenesis, Female, Drug Monitoring, Multiple Myeloma, medicine.drug, medicine.medical_specialty, Immunology, 03 medical and health sciences, Internal medicine, Biomarkers, Tumor, Humans, Survival analysis, Aged, Monitoring, Physiologic, business.industry, Immunity, Cell Biology, medicine.disease, Survival Analysis, Minimal residual disease, Clinical trial, Transplantation, body regions, Concomitant, Prednisone, business, 030215 immunology

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e53803bf8a168a0aefd84e3ef3c57fecTest
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=3240Test

المؤلفون: Mateos, María-Victoria¹, Marínez-López, Joaquín², Hernández, Miguel-Teodoro³, Ocio, Enrique-M.¹, Rosiñol, Laura⁴, Martínez, Rafael⁵, Teruel, Ana-Isabel⁶, Gutiérrez, Norma C.¹, Ramos, María-Luisa Martín², Oriol, Albert⁷, Bargay, Joan⁸, Bengoechea, Enrique⁹, González, Yolanda¹⁰, de Oteyza, Jaime Pérez¹¹, Gironella, Mercedes¹², Encinas, Cristina¹³, Martín, Jesús¹⁴, Cabrera, Carmen¹⁵, Paiva, Bruno¹⁶, Cedena, María-Teresa²

المصدر: Blood. 1/28/2016, Vol. 127 Issue 4, p420-425. 6p.

مصطلحات موضوعية: *BORTEZOMIB, *MELPHALAN, *DEXAMETHASONE, *MULTIPLE myeloma treatment, *OLDER patients, *RANDOMIZED controlled trials, *PROGRESSION-free survival, *THERAPEUTICS